Education and Communication on the Topic of Osteonecrosis of the Jaw When Taking Bone-Stabilizing Drugs

IF 1.7 Q3 DENTISTRY, ORAL SURGERY & MEDICINE

Clinical and Experimental Dental Research Pub Date : 2024-11-04 DOI:10.1002/cre2.70024

Franz Gustav Saur, Christian Keinki, Alin Cramer, Jens Buentzel, Jutta Hübner

{"title":"Education and Communication on the Topic of Osteonecrosis of the Jaw When Taking Bone-Stabilizing Drugs","authors":"Franz Gustav Saur, Christian Keinki, Alin Cramer, Jens Buentzel, Jutta Hübner","doi":"10.1002/cre2.70024","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>The aim of this study was to analyze the communication between doctors and patients who were taking bone-stabilizing medication and in rare cases developed osteonecrosis of the jaw as a result.</p>\n </section>\n \n <section>\n \n <h3> Material and Methods</h3>\n \n <p>A standardized questionnaire recorded deficits based on patient experiences. These data were used to develop solution strategies for improving doctor–patient communication and the benefit–risk assessment of medication use.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Most patients were satisfied with the information provided by their doctor; however, one in three (29.8%) were not informed about possible side effects, and a quarter (24.6%) only found out about osteonecrosis of the jaw through their own research. Only half (45.7%) were asked about risk factors, and most information materials were rated poorly. The diagnosis took an average of 18.7 months, with many (47.8%) consulting a doctor only when they experienced pain. Quality of life was severely impaired, with daily pain, physical limitations, and negative effects on mental health. About a third (35.3%) reported that their quality of life had deteriorated significantly.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Further research into patient education is necessary. Web-based information brochures, improved follow-up care, and close cooperation with dentists are required. The use of a running sheet, such as the AGSMO running sheet, for individual risk assessment of osteonecrosis of the jaw is recommended. Patients undergoing treatment with bone-stabilizing medication should be monitored closely. Education about osteonecrosis of the jaw must be continued, and the medical profession must be confronted with it.</p>\n </section>\n </div>","PeriodicalId":10203,"journal":{"name":"Clinical and Experimental Dental Research","volume":"10 6","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cre2.70024","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dental Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cre2.70024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

The aim of this study was to analyze the communication between doctors and patients who were taking bone-stabilizing medication and in rare cases developed osteonecrosis of the jaw as a result.

Material and Methods

A standardized questionnaire recorded deficits based on patient experiences. These data were used to develop solution strategies for improving doctor–patient communication and the benefit–risk assessment of medication use.

Results

Most patients were satisfied with the information provided by their doctor; however, one in three (29.8%) were not informed about possible side effects, and a quarter (24.6%) only found out about osteonecrosis of the jaw through their own research. Only half (45.7%) were asked about risk factors, and most information materials were rated poorly. The diagnosis took an average of 18.7 months, with many (47.8%) consulting a doctor only when they experienced pain. Quality of life was severely impaired, with daily pain, physical limitations, and negative effects on mental health. About a third (35.3%) reported that their quality of life had deteriorated significantly.

Conclusions

Further research into patient education is necessary. Web-based information brochures, improved follow-up care, and close cooperation with dentists are required. The use of a running sheet, such as the AGSMO running sheet, for individual risk assessment of osteonecrosis of the jaw is recommended. Patients undergoing treatment with bone-stabilizing medication should be monitored closely. Education about osteonecrosis of the jaw must be continued, and the medical profession must be confronted with it.

Abstract Image

查看原文本刊更多论文

关于服用骨稳定药物时颌骨坏死主题的教育和交流。

研究目的本研究的目的是分析医生与服用骨稳定药物的患者之间的沟通情况，在极少数情况下，患者会因此患上颌骨坏死：一份标准化问卷记录了基于患者经验的缺陷。结果：大多数患者对所提供的信息表示满意：大多数患者对医生提供的信息表示满意；然而，三分之一（29.8%）的患者未被告知可能出现的副作用，四分之一（24.6%）的患者仅通过自己的调查了解到颌骨坏死。只有一半（45.7%）的人被问及风险因素，大多数信息资料的评分都很低。诊断平均需要18.7个月，许多人（47.8%）只有在出现疼痛时才去看医生。他们的生活质量受到严重影响，每天都感到疼痛，身体受到限制，心理健康也受到负面影响。约有三分之一（35.3%）的患者表示他们的生活质量严重下降：结论：有必要对患者教育开展进一步研究。结论：有必要对患者教育进行进一步研究，需要制作基于网络的信息手册，改善后续护理，并与牙医密切合作。建议使用诸如 AGSMO 的流水单对颌骨坏死进行个体风险评估。对接受骨稳定药物治疗的患者应进行密切监测。必须继续开展有关颌骨坏死的教育，并使医学界正视这一问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Dental Research DENTISTRY, ORAL SURGERY & MEDICINE-

CiteScore

3.30

自引率

5.60%

发文量

165

审稿时长

26 weeks

期刊介绍： Clinical and Experimental Dental Research aims to provide open access peer-reviewed publications of high scientific quality representing original clinical, diagnostic or experimental work within all disciplines and fields of oral medicine and dentistry. The scope of Clinical and Experimental Dental Research comprises original research material on the anatomy, physiology and pathology of oro-facial, oro-pharyngeal and maxillofacial tissues, and functions and dysfunctions within the stomatognathic system, and the epidemiology, aetiology, prevention, diagnosis, prognosis and therapy of diseases and conditions that have an effect on the homeostasis of the mouth, jaws, and closely associated structures, as well as the healing and regeneration and the clinical aspects of replacement of hard and soft tissues with biomaterials, and the rehabilitation of stomatognathic functions. Studies that bring new knowledge on how to advance health on the individual or public health levels, including interactions between oral and general health and ill-health are welcome.